Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
Probin Kr Roy, Johirul Islam, H. Lalhlenmawia2023The Egyptian Heart JournalReview
Endocrine (ADH/ACTH/MSH)
Abstract
This review offers an overview on the pathophysiology of obesity, management of obesity-linked disorders, and areas in need of attention such as novel therapeutic adipokines and their possible future perspectives as therapeutic agents.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- Pro-resolving and anti-arthritic properties of the MC1 selective agonist PL8177Frontiers in Immunology · 2022 · 1 shared tag
- Probing the VIPR2 Microduplication Linkage to Schizophrenia in Animal and Cellular ModelsFrontiers in Neuroscience · 2021 · 1 shared tag
- CGRP sensory neurons promote tissue healing via neutrophils and macrophagesNature · 2024 · 1 shared tag
- Invited review: Mechanisms of hypophagia during diseaseJournal of Dairy Science · 2021 · 1 shared tag
- Considering traditional Chinese medicine as adjunct therapy in the management of chronic constipation by regulating intestinal floraBioScience Trends · 2024 · 1 shared tag
- Lipid-Induced Insulin Resistance Mechanisms: The Link to Inflammation and Type 2 Diabetes.2021 · 1 shared tag